CNS Pharmaceuticals
CNSP

CNS Pharmaceuticals (CNSP) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$6.42
EPS estimate
−$9.60
Revenue
$0.00
Reported
Aug 14, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 14, 2025−$9.60−$6.42+33.13%$0.00SEC
Q1 2025May 15, 2025−$24.00−$18.96+21.00%$0.00SEC
Q4 2024Mar 31, 2025−$87.96−$447.96−409.28%$0.00SEC
Q3 2024Nov 14, 2024−$60.00−$150.00−150.00%$0.00SEC
Q2 2024Aug 14, 2024$0.00−$4,032.00+0.00%$0.00SEC
Q3 2023Nov 14, 2023−$51,900.00−$32,400.00+37.57%$0.00SEC
Q1 2023May 15, 2023$0.00−$77,700.00+0.00%$0.00SEC
Q4 2022Mar 31, 2023−$72,000.00−$111,300.00−54.58%$0.00SEC
Q2 2022Aug 12, 2022−$54,000.00−$81,000.00−50.00%$0.00
Q3 2021Nov 12, 2021−$120,000.00−$126,000.00−5.00%$0.00
Q2 2021Aug 13, 2021−$117,000.00−$135,000.00−15.38%$0.00
Q1 2020May 15, 2020−$108,000.00−$108,000.00+0.00%$0.00

Quarterly revenue

Q1 2020
$0.00
Q2 2021
$0.00
Q3 2021
$0.00
Q2 2022
$0.00
Q4 2022
$0.00
Q1 2023
$0.00
Q3 2023
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00

Frequently asked questions

  • When did CNS Pharmaceuticals (CNSP) last report earnings?

    CNS Pharmaceuticals last reported on Aug 14, 2025, covering fiscal Q2 2025.

  • Did CNSP beat earnings estimates?

    Yes. CNS Pharmaceuticals reported EPS of −$6.42 for Q2 2025 against a −$9.60 estimate — a 33.13% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.